Author: Choudhry, Hani; Bakhrebah, Muhammed A; Abdulaal, Wesam H; Zamzami, Mazin A; Baothman, Othman A; Hassan, Mohammed A; Zeyadi, Mustafa; Helmi, Nawal; Alzahrani, Faisal; Ali, Ashraf; Zakaria, Mohammad Khalid; Kamal, Mohammad Azhar; Warsi, Mohiuddin Khan; Ahmed, Firoz; Rasool, Mahmood; Jamal, Mohammad Sarwar
Title: Middle East respiratory syndrome: pathogenesis and therapeutic developments Cord-id: nomfciyu Document date: 2019_4_18
ID: nomfciyu
Snippet: The first case of Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in the year 2012, which spread rapidly and increased to more than 2200 in 2018. This highly pathogenic virus with high mortality rate is among one of the major public health concerns. Saudi Arabia remains to be the most affected region with the majority of MERS-CoV cases, and currently, no effective drugs and vaccines are available for prevention and treatment. A large amount of information is now available
Document: The first case of Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in the year 2012, which spread rapidly and increased to more than 2200 in 2018. This highly pathogenic virus with high mortality rate is among one of the major public health concerns. Saudi Arabia remains to be the most affected region with the majority of MERS-CoV cases, and currently, no effective drugs and vaccines are available for prevention and treatment. A large amount of information is now available regarding the virus, its structure, route of transmission and its pathophysiology. Therefore, this review summarizes the current understanding of MERS-CoV's pathogenesis, treatment options and recent scientific advancements in vaccine and other therapeutic developments, and the major steps taken for MERS prevention control.
Search related documents:
Co phrase search for related documents- abdulaziz city and acute respiratory syndrome coronavirus: 1, 2, 3
- abdulaziz university and acute respiratory: 1, 2, 3, 4, 5
- abdulaziz university and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5
- achieve strategy and acute respiratory: 1, 2, 3, 4, 5, 6, 7
- achieve strategy and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6
- acute respiratory and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and adequate management: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and adjuvant suitable combination: 1
- acute respiratory and low respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- acute respiratory and lung present: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and lung tissue infiltration: 1, 2, 3, 4, 5, 6
- acute respiratory syndrome coronavirus and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome coronavirus and adequate management: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- acute respiratory syndrome coronavirus and adjuvant suitable combination: 1
- acute respiratory syndrome coronavirus and low respiratory tract: 1, 2, 3, 4, 5
- acute respiratory syndrome coronavirus and lung present: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome coronavirus and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome coronavirus and lung tissue infiltration: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date